Advertisement

Topics

Sepracor Company Profile

18:18 EST 21st November 2017 | BioPortfolio

Sepracor Incorporated is a specialty pharmaceutical company focused on the cost-effective development of safer, purerand more effective drugs that are improved versions of widely-prescribed pharmaceutical compounds. Typically, these improved chemical entities ("ICEs") are patented, single-isomer or active-metabolite forms of the parent compound. Sepracor selects for development widely-sold parent drugs with potential for improved efficacy, side-effect profile, or both. Sepracor develops these drugs by leveraging its broad patent position, expertise in chiral chemistry and pharmacology, and experience in conducting clinical trials and seeking regulatory approvals for new drugs. Sepracor's drug development program has yielded an extensive portfolio of drug candidates intended to treat a broad range of indications. To date, certain of these candidates are being developed at lower cost and in less time than the new chemical entities ("NCEs") that characterize traditional drug development.

Location

84 Waterford Drive
Marlborough
MA
01752
United States of America

Contact

Phone: 508-481-6700
Fax: 508 481 7683
Email: info@sepracor.com


News Articles [1 Associated News Articles listed on BioPortfolio]

PTV News: Sep 3, 2009

Top stories on September 3rd, 2009: Japan goes west as Dainippon Sumitomo buys Sepracor PTC's GEMS dazzle Roche India rejects patent protection for Gilead’s HIV drug Double vision as Abbot buys Vis...

Drugs and Medications [4 Associated Drugs and Medications listed on BioPortfolio]

Xopenex [Rebel Distributors Corp]

Xopenex (levalbuterol HCl) Inhalation Solution 0.31 mg*, 0.63 mg*, 1.25 mg*

Xopenex hfa [Sunovion Pharmaceuticals Inc.]

XOPENEX HFA (levalbuterol tartrate) Inhalation Aerosol

Xopenex [Sunovion Pharmaceuticals Inc.]

Xopenex (levalbuterol HCl) Inhalation Solution 0.31 mg*, 0.63 mg*, 1.25 mg*

Alvesco [Sunovion Pharmaceuticals Inc.]

These highlights do not include all the information needed to use ALVESCO safely and effectively. See full prescribing information for ALVESCO. ALVESCO (ciclesonide) Inhalation Aerosol 80 mcg, 160 mcg...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [5 Associated Companies listed on BioPortfolio]

HemaSure Incorporated

HemaSure Inc. is a wholly-owned subsidiary of Sepracor Inc. ("Sepracor"). Sepracor transferred to the Hemasure its technology relating to the manufacture, use and sale of medical devices for the...

Sepracor Inc.

Sepracor Inc., an indirect, wholly-owned subsidiary of Dainippon Sumitomo Pharma Co., Ltd., is a research-based pharmaceutical company dedicated to treating and preventing human d...

Dainippon Sumitomo Pharma America, Inc.

Dainippon Sumitomo Pharma America, Inc. (DSPA) located in Fort Lee, N.J., is a subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP). On April 1, 2010, DSP's two North American operations - DSPA and...

Sepracor

Sepracor Incorporated is a specialty pharmaceutical company focused on the cost-effective development of safer, purerand more effective drugs that are improved versions of widely-prescribed pharmaceut...

Allergy and Asthma Associates

Allergy and Asthma Associates is one of the oldest allergy-asthma practices in the Pacific Northwest starting in 1938 by James Stroh, Sr. Drs. James Stroh, Jr and Rick Lane Johnson joined Dr. Stroh in...

More Information about "Sepracor" on BioPortfolio

We have published hundreds of Sepracor news stories on BioPortfolio along with dozens of Sepracor Clinical Trials and PubMed Articles about Sepracor for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sepracor Companies in our database. You can also find out about relevant Sepracor Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record